Molecular characterization and therapeutic reaction to dasatinib in a CML patient harboring a novel e8a2 BCR-ABL1 transcript with a somatic mutation in TP53BP2 and cadherin-10 genes.
about
Molecular characterization and therapeutic reaction to dasatinib in a CML patient harboring a novel e8a2 BCR-ABL1 transcript with a somatic mutation in TP53BP2 and cadherin-10 genes.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Molecular characterization and ...... TP53BP2 and cadherin-10 genes.
@en
Molecular characterization and ...... TP53BP2 and cadherin-10 genes.
@nl
type
label
Molecular characterization and ...... TP53BP2 and cadherin-10 genes.
@en
Molecular characterization and ...... TP53BP2 and cadherin-10 genes.
@nl
prefLabel
Molecular characterization and ...... TP53BP2 and cadherin-10 genes.
@en
Molecular characterization and ...... TP53BP2 and cadherin-10 genes.
@nl
P2093
P2860
P1433
P1476
Molecular characterization and ...... TP53BP2 and cadherin-10 genes.
@en
P2093
Chun-Hong Hu
Guang-Sen Zhang
Su-Fang Liu
Wen-Zhe Yan
Yang Zhang
Zhao Cheng
P2860
P304
P356
10.1080/10428194.2017.1323269
P577
2017-05-30T00:00:00Z